baber/WOPTO huggingface dataset:
Patent AU-730310-B2 (AU)
Title: Dihydrobenzofuran compounds useful as anti-inflammatory agents
Inventor: SCHERZ MICHAEL WIARD
IPC: C07D405/06
Filed: 1997-01-30
Granted: 2001-03-01
Abstract: A compound having the structure:   <IMAGE>   wherein (a) n is from 1 to about 3; (b) X is selected from the group consisting of O, S, SO, or SO2; (c) Y is independently hydrogen or straight, branched or cyclic alkyl having from 1 to about 4 carbon atoms, or the Y's are bonded together to form an alkanyl ring having from 3 to about 7 atoms; (d) Z is hydrogen or straight, branched or cyclic alkyl having from 3 to about 10 atoms other than hydrogen; (e) W is hydrogen or straight, branched or cyclic alkyl, aryl, hydroxy or alkoxy; and (f) R1 and R2 are independently hydrogen or straight, branched or cyclic alkyl having from one to 10 carbon atoms, aryl, heterocyclyl, heteroaryl, hydroxy, or alkoxy; or R1 and R2 are bonded together to form a ring having from from 3 to about 7 atoms wherein one to three atoms may be heteroatoms. pharmaceutical compositions comprising such compounds, and methods of treating inflammation or pain using such compounds.
Patent AU-754406-B2 (AU)
Title: Improved knife holder for a chipper disc
Inventor: SWARTWOOD TROY M
IPC: B02C18/14
Filed: 1999-11-18
Granted: 2002-11-14
Abstract: An improved knife holder for a chipper disc. A knife holder for boding a knife has a first clamping portion and a second clamping portion for clamping the knife therebetween. One of the clamping portions pivots about a pivot point for clamping the knife and for releasing the knife so that it may be easily removed from the knife holder. In the relative position of the clamping portions in which the knife is clamped and in their relative positions in which a space is opened up around the knife permitting its removal, the clamping portions are rigidly disposed with respect to one another.
Patent AU-660039-B2 (AU)
Title: Echogenic particles, a process for their production and their use
Inventor: ZOTZ RAINER
IPC: A61K49/22
Filed: 1992-09-02
Granted: 1995-06-08
Abstract: The present invention describes echogenic particles with a smooth surface and/or echogenic particles with 1 to 10 concave surface segments, the preparation thereof by spray drying, and the use thereof as ultrasonic diagnostic aid.
Patent AU-774871-B2 (AU)
Title: Fuel cell battery with afterburning at the periphery of a cell stack
Inventor: DOGGWILER BRUNO
IPC: H01M8/2425
Filed: 2000-03-16
Granted: 2004-07-08
Abstract: The fuel cell battery has at least one air or oxygen-containing gas inlet point (25) for each cell and post-combustion occurs in an annular chamber around the cell stack.. The inlet points communicate as a whole or in groups via at least one air chamber (115) extending axially along the stack and in direct contact with it. Each air chamber is divided from a post-combustion chamber (4) by at least one dividing wall (40).
Patent AU-624082-B2 (AU)
Title: Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
Inventor: SCHNEIDER MARTIN DR
IPC: A61K31/565
Filed: 1988-09-30
Granted: 1992-06-04
Abstract: Agents, containing at least one compound having antiprogestational activity and at least one compound having anti-estrogenic activity, are suitable for the treatment of hormone-dependent tumors.
Patent AU-730931-B2 (AU)
Title: Methods of terminal sterilization of biological products
Inventor: KAMPINGA JAAP
IPC: A61K31/57
Filed: 1997-05-14
Granted: 2001-03-22
Abstract: The invention relates to methods of sterilizing biologically active products, particularly therapeutic or prophylactic products and the compositions obtained thereby. The methods include obtaining a dried sample containing an amount of trehalose sufficient to render heat stability to the product and exposing the dried sample to heating conditions at a temperature and for a duration sufficient to substantially inactivate viruses, especially non-lipid encapsulated viruses. The drying methods include both ambient drying conditions and lyophilization. The heating conditions include any known in the art and cover a wide range of temperatures and heating times. The compositions obtained contain stable products and do not contain measurable infectious virus, particularly parvovirus.
Patent AU-691317-B2 (AU)
Title: Biodegradable polymers, process for their production and their use in producing biodegradable mouldings
Inventor: WARZELHAN VOLKER
IPC: C08G18/42
Filed: 1995-06-27
Granted: 1998-05-14
Abstract: Biodegradable polyether esters P1 obtainable by reacting a mixture essentially comprising(a1) a mixture essentially comprising20-95 mol % of adipic acid or ester-forming derivatives thereof or mixtures thereof,5-80 mol % of terephthalic acid or ester-forming derivatives thereof or mixtures thereof, and0-5 mol % of a compound containing sulfonate groups,where the total of the individual mole percentages is 100 mol %, and(a2) a mixture of dihydroxy compounds essentially comprising(a21) from 15 to 99.8 mol % of a dihydroxy compound selected from the group consisting of C2-C6-alkanediols and C5-C10-cycloalkanediols,(a22) from 85 to 0.2 mol % of a dihydroxy compound containing ether functionalities of the formula Iwhere n is 2, 3 or 4 and m is an integer from 2 to 250, or mixtures thereof,where the molar ratio of (a1) to (a2) is chosen in the range from 0.4:1 to 1.5:1, with the proviso that the polyether ester P1 has a molecular weight (Mn) in the range from 5000 to 80,000 g/mol, a viscosity number in the range from 30 to 450 g/ml (measured in o-dichlorobenzene/phenol (50/50 ratio by weight) at a concentration of 0.5% by weight of polyether ester P1 at 25° C.) and a melting point in the range from 50 to 200° C., and with the further proviso that from 0.01 to 5 mol %, based on the molar quantity of component (a1) employed, of a compound D with at least three groups capable of ester formation are employed to prepare the polyether ester P1,and further biodegradable polymers and thermoplastic molding compositions, processes for the preparation thereof, the use thereof for producing biodegradable moldings and adhesives, biodegradable moldings, films and blends with starch obtainable from the polymers and molding compositions according to the invention.
Patent AU-567747-B2 (AU)
Title: Early detection of mammalian pregnancy
Inventor: SASSER R GARTH
IPC: G01N33/534
Filed: 1984-07-16
Granted: 1987-12-03
Abstract: Early pregnancy can be determined by detection of a protein in serum, which protein is associated with the placental membrane. The protein is characterized by having an approximate molecular weight of 47,000 to 53,000 and an isoelectric point of from about 4.0-4.4.
Patent AU-771504-B2 (AU)
Title: Quinoline derivatives and quinazoline derivatives
Inventor: KUBO KAZUO
IPC: C07D215/22
Filed: 2000-01-20
Granted: 2004-03-25
Abstract: An object of the present invention is to provide compounds which have antitumor activity and do not change cytomorphosis. Disclosed are compounds represented by formula (I) and a pharmaceutically acceptable salts and solvates thereof and pharmaceutical compositions comprising said compounds: <CHEM> wherein X and Z each independently represent CH or N; R<1> to R<3> represent H, substituted alkoxy, unsubstituted alkoxy or the like; R<4> represents H; R<5> to R<8> represent H, halogen, alkyl, alkoxy, alkylthio, nitro, or amino, provided that R<5> to R<8> do not simultaneously represent H; R<9> and R<10> represent H, alkyl, or alkylcarbonyl; and R<11> represents alkyl, alkenyl, alkynyl, or aralkyl.
Patent AU-655347-B2 (AU)
Title: Osteosynthesis aid for pertrochanteric fractures of the neck of the femur
Inventor: PENNIG DIETMAR
IPC: A61B17/58
Filed: 1992-12-11
Granted: 1994-12-15
Abstract: The invention relates to an osteosynthesis helping device, i.e. an osteosynthesis plate (4), which can be firmly connected to a medullary pin (3). At the same time, it relates especially to an osteosynthesis helping device for femoral neck fractures, comprising a medullary pin (3) for the proximal region (A) of the femoral bone, a connection provided on its outer end for an osteosynthesis plate, and an osteosynthesis plate having bores for the reception of bone screws (6, 2), one set of bone screws (6) serving to fix the osteosynthesis plate on the femur and the other set of bone screws (2) serving to connect the osteosynthesis plate (4) to the neck of the femur, and, furthermore, the bores having a transversal spacing which is larger than the diameter of the medullary pin (3). It is also possible to fix an osteosynthesis plate to the head of the humerus by means of screws to which a medullary pin can be firmly connected. <IMAGE>
Patent AU-574392-B2 (AU)
Title: Laser catheter for ablation of lesions in a blood vessel
Inventor: LINSKER RALPH
IPC: A61B17/22
Filed: 1984-10-16
Granted: 1988-07-07
Abstract: Lesions in human blood vessels may be removed with little or no thermal damage to vessel wall, and with reduced risk of accidental wall perforation, using a catheter which delivers laser energy in the 210 to 320 nanometer wavelength range. The laser energy is transmitted from source (4) through an elastomer-clad high-purity silica optical fibre (5) positioned in a catheter sheath (7), and the sheath exhausts lesion destruction products. The source (4) includes two lasers, the first producing the energy in the 210 to 320 nanometer wavelength range, and the second laser producing energy into the visible range, the second laser being operated to remove remaining calcified portions of a lesion after the main organic part has been removed by the first laser.
Patent AU-2002239766-B2 (AU)
Title: Methods of treating disorders related to apoE
Inventor: HUANG YADONG
IPC: C12N5/0793
Filed: 2001-11-02
Granted: 2006-11-09
Abstract: The present invention provides methods inhibiting formation of neurofibrillary tangles; and methods for treating disorders relating to apolipoprotein E (apoE) in a subject. The methods generally involve reducing the level of a carboxyl-terminal truncated form of apoE in a neuronal cell of a subject. The invention further provides isolated cells comprising a nucleic acid molecule encoding a carboxyl-terminal truncated form of apoE; and methods of screening compounds using the cells. The invention further provides compounds that inhibit an apoE cleavage enzyme, and that reduce the formation of neurofibrillary tangles in a neuronal cell. The invention further provides transgenic non-human animals that include as a transgene a nucleic acid that encodes a carboxyl-terminal truncated form of apoE; as well as methods of screening compounds using transgenic animals.
Patent AU-720065-B2 (AU)
Title: Method and installation for the processing of plastic tubes with biaxial stretching
Inventor: PREVOTAT BERNARD
IPC: B29C55/26
Filed: 1997-09-18
Granted: 2000-05-25
Abstract: The invention concerns a method for treating plastic tubes, in particular PCV tubes, obtained by extrusion, whereby a tube is brought to a molecular orientation temperature, higher than room temperature, and is subjected to bi-axial drawing by radial expansion and axial elongation, to obtain a bi-oriented tube whose mechanical properties are improved. The tube (T) is cut into elements (4) of predetermined length immediately after being extruded and its temperature is higher than the molecular orientation temperature, each element constituting a blank (5); each blank (5) is placed in a chamber (E) to be cooled therein by a fluid (F) to a temperature close to the molecular orientation temperature, the dwell time of the blank in the chamber being greater than the time of its production by extrusion; and the blank (5) is then extracted from the chamber (E) to be subjected to a treatment enabling its bi-orientation.
Patent AU-617546-B2 (AU)
Title: Sheathed electric heating element assembly
Inventor: CUNNINGHAM DONALD MATHEW
IPC: H05B3/48
Filed: 1989-10-18
Granted: 1991-11-28
Abstract: In a metallic sheathed electric heating element assembly (1) having a resistance element (10), a sheath (5) surrounding the resistance element (10), pulverulent electrically insulating material (15) within the sheath (5) and surrounding the resistance element (10), the insulating material being tightly compacted and extending within the sheath (5) short of an open end thereof, and a terminal pin (20) electrically and mechanically connected to an end of the resistance element (10) within the compass of the sheath (5), the terminal pin (20) is made in two parts, an inner part (21) to which the resistance element (10) is connected, and an outer part (23) spaced from the inner part (21), and a thermal switch or cutoff electrically connected to and in series between the inner and outer parts (21,23) of the pin (20) within the sheath (5) but spaced toward the open end from the compacted insulating material (15), the thermal switch being in good thermal contact with the inner part (21) of the terminal pin (20).
Patent AU-715243-B2 (AU)
Title: Acellular antibordetella vaccine
Inventor: GUEIRARD PASCALE
IPC: A61K39/00
Filed: 1995-12-15
Granted: 2000-01-20
Abstract: Novel immunogenic compsn. (I) comprises:(a) at least an immunogenic part of an adenyl-cyclase-haemolysin (AC-Hly) protein from Bordetella pertussis (Bp), B. parapertussis (Bpp) or B. bronchiseptica (Bb), and(b) a bacterial extract contg. at least a part of the expression products of vrg genes of Bp, Bpp or Bb.
Patent AU-719392-B2 (AU)
Title: Nitrogen-containing heterocyclic compounds
Inventor: MATSUNO KENJI
IPC: C07D403/12
Filed: 1997-10-01
Granted: 2000-05-11
Abstract: The present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of PDGF receptor to hinder abnormal cell growth and cell wandering and thus are useful for the prevention or treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis. The compounds are represented by general formula (I): <CHEM>       wherein V represents an oxygen atom or a sulfur atom; W represents 1,4-piperazinediyl or 1,4-homopiperazinediyl in which carbons on the ring may be substituted by unsubstituted alkyl groups;     X represents a nitrogen atom or C-R<9>;   Y represents a nitrogen atom or C-R<8>; Z represents a nitrogen atom or C-R<7> (provided that at least one of X, Y and Z represents a nitrogen atom); R<1> represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alicyclic alkyl group, etc.; R<2> represents a substituted alkyl group, a substituted or unsubstituted alicyclic alkyl group, etc.; R<3>, R<4>, R<5> and R<6>, which may be the same or different, each represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a nitro group, a cyano group, - OR<12>, -NR<15>R<16>, etc.;   R<7> represents a halogen atom, etc.;   R<8> has the same significance as R<7>, and R<9> represents a hydrogen atom or -COR<41>.
Patent AU-630123-B2 (AU)
Title: Cyclopropylpentadienamides and their use as pesticides
Inventor: BLADE ROBERT JOHN
IPC: A01P7/02
Filed: 1989-11-15
Granted: 1992-10-22
Abstract: 1) The present Application discloses pesticidally active compounds of the formula (I):  Q Q<1> CR<2> = CR<3> CR<4> = CR<5>C (=X) NHR<1> or a salt thereof, wherein Q is an monocyclic aromatic ring, or fused bicyclic ring system of which at least one ring is aromatic containing 9 or 10 atoms of which one may be nitrogen and the rest carbon each optionally substituted, or Q is a dihalovinyl group or a group R<6>-C IDENTICAL C- where R<6> is C1-4 alkyl, tri C1-4 alkylsilyl, halogen or hydrogen; Q<1> is a 1,2-cyclopropyl ring optionally substituted by one or more groups selected from C1-3 alkyl, halo, C1-3 haloalkyl, alkynyl, or cyano; R<2>,R<3>, R<4> and R<5> are the same or different with at least one being hydrogen and the others being independently selected from hydrogen, halo, C1-4 alkyl or C1-4 haloalkyl; X is oxygen or sulphur; and R<1> is selected from hydrogen and C1-8 hydrocarbyl optionally substituted by dioxalanyl, halo, cyano, trifuoromethyl, trifluoromethylthio or C1-6 alkoxy, their preparation, pesticidal compositions containing them and their use against pests.
Patent AU-782256-B2 (AU)
Title: Tinted lenses and methods of manufacture
Inventor: DOSHI PRAFUL
IPC: B29D11/00
Filed: 2000-10-23
Granted: 2005-07-14
Abstract: The present invention recognizes that lenses, such as contact lenses, can be pigmented using ink that include polymers or polymerizable monomers, preferably the same monomers used to make the lens. The ink can be used to make images on or within the lens. Images made using these inks are preferably digital and can be used in a variety of printing methods, including ink-jet printing.
Patent AU-754493-B2 (AU)
Title: Expansible implant for vascular embolization and method of making the same
Inventor: GREENE GEORGE R JR
IPC: A61F2/02
Filed: 1999-07-02
Granted: 2002-11-21
Abstract: A vascular implant formed of a compressible foam material has a compressed configuration from which it is expansible into a configuration substantially conforming to the shape and size of a vascular site to be embolized. Preferably, the implant is formed of a hydrophilic, macroporous foam material, having an initial configuration of a scaled-down model of the vascular site, from which it is compressible into the compressed configuration. The implant is made by scanning the vascular site to create a digitized scan data set; using the scan data set to create a three-dimensional digitized virtual model of the vascular site; using the virtual model to create a scaled-down physical mold of the vascular site; and using the mold to create a vascular implant in the form of a scaled-down model of the vascular site.
Patent AU-620492-B2 (AU)
Title: Novel adapter for catheters
Inventor: GROSS JAMES R
IPC: A61M25/00
Filed: 1990-02-05
Granted: 1992-02-20
Abstract: There is disclosed a novel unitary adapter (100) for placing a catheter (136) in fluid communication with a source of liquid medication, such as a syringe, comprising a catheter connector (102) for releasably securing the proximal end of a catheter (136) extending from a patient's body for receiving the said medication, and a connector (104) releasably engaging the said liquid medication source, the said connectors (102,104) being attached to one another and movable between an open position for inserting the said catheter end in the connector (102) and a closed position for securing the said catheter end within the said connector (102), and locking means (118, 120) for retaining the said connectors (102,104) in the said closed position, thereby to prevent accidental opening and the resulting falling out of the said catheter end from the said adapter (100). The catheter (136) is preferably one for continuous spinal or continuous epidural anesthesia procedures.
Patent AU-619944-B2 (AU)
Title: A method of controlling the frequency of a coherent radio receiver and apparatus for carrying out the method
Inventor: RAITH ALEX KRISTER
IPC: H04L27/233
Filed: 1990-01-04
Granted: 1992-02-06
Abstract: The invention relates to a method and an arrangement for controlling the frequency of a radio-receiver which receives signal-sequencies which have been subjected to interference and which include a synchronizing-sequence and a data-sequence. A signal-sequence is A/D-converted (3) to signal-points (I,Q) intended for analysis, and a Viterbi-algorithm (10) is adapted (12,13) to the prevailing interferencies with the aid of the synchronizing-sequence. The data-sequence is Viterbi-analyzed through a large number of calculating stages, for the purpose of determining the bit-sequence of the data-sequence. According to the invention, a bit-sequence is extracted during the Viterbi-analysis, with a time-delay (TE), subsequent to effecting a few calculating stages, and a corresponding extracted signal-point is calculated (14). The analysis-intended signal-point corresponding to the extracted signal-point is divided and time-delayed (16,TE), and phase-compared (15) with the extracted signal-point. Corresponding phase-comparisons are made with respect to consecutive signal-points in the data-sequence and the angular magnitudes obtained in the phase-comparison are low-pass filtered and integrated (17) to form an angle-shift signal (V). The analysis-intended signal-points are displaced angularly (11) by the angle-shift signal (V) prior to the Viterbi-analysis.
Patent AU-686571-B2 (AU)
Title: Subsequent working process for a tin sealing cap
Inventor: STRUBE LUTZ
IPC: B21D51/44
Filed: 1993-10-08
Granted: 1998-02-12
Abstract: PCT No. PCT/DE93/00958 Sec. 371 Date May 17, 1996 Sec. 102(e) Date May 17, 1996 PCT Filed Oct. 8, 1993 PCT Pub. No. WO95/10373 PCT Pub. Date Apr. 20, 1995A process for further treating a closure end made of sheet material is provided, particularly for beverage cans, in which an annular fringe region is radially coupled between the central panel portion and a radius of curvature coupled to a core groove with an inner leg. The central panel portion is squeezed such that material is displaced (flows) from the fringe region in a substantially radial outward direction towards the radius of curvature. The squeezing is accomplished by a coining tool having a coining surface operable to contact the closure end. The closure surface is pressed against the closure end causing the thickness of the sheet material of the closure end to be reduced in the annular fringe region. The reduction in thickness gradually decreasing in the direction of the radius of curvature. The material displaced by the squeezing flowing towards the radius of curvature. A ring tool which is finger like in cross section can be used to exert pressure on the core groove during or after the squeezing thereby causing the inner leg of the core groove to move towards a more vertical orientation.
Patent AU-526323-B2 (AU)
Title: Basic ethers
Inventor: GANTE JOACHIM
IPC: C07D233/60
Filed: 1979-09-27
Granted: 1983-01-06
Abstract: For the Contracting States : BE, CH, DE, FR, GB, IT, NL, SE 1. Basic ethers of the general formula I  see diagramm : EP0009683,P12,F1 wherein G is an unsubstituted phenyl oder benzyl group or a phenyl or benzyl group which is monosubstituted or disubstituted by halogen or is alkyl with 1-6 C atoms, Z is 1-imidazolyl or 2-methyl-1-imidazolyl, A is -CH=CR**1-, -CO-CHR**1-, -CHOH-CHR**1- or -CH2 -CHR**2-, n is 1, 2 or 3, R**1 is H or alkyl with 1-4 C atoms and R**2 is alkyl with 1-4 C atoms, and their physiologically acceptable acid addition salts. For the Contracting State : AT 1. Process for the preparation of basic ethers of the general formula I see diagramm : EP0009683,P13,F1  dans laquelle A is -CH=CR**1-, -CO-CHR**1, -CHOH-CHR**1- or -CH2 -CHR**2-. n is 1, 2 or 3, R**1 is H or alkyl with 1-4 C atoms and R**2 is alkyl with 1-4 C atoms, and their physiologically acceptable acid addition salts, characterized in that a compound of the general formula II R-Q wherein R is the group C-O-  see diagramm : EP0009683,P13,F2  and Q is a radical which can be reduced to a group -A-(CH2 )n -Z, and G, Z, A and n have the meaning indicated above, is treated with a reducing agent, or in that a compound which corresponds to the general formula I but in which the hydroxyl group is present in a functionally modified form is treated with a solvolyzing agent with liberation of the hydroxyl group, or in that a compound of the general formula III R-A-(CH2 )n -X wherein X is Cl, Br, I, OH or reactively functionally modified OH and R, A and n have the meaning indicated above, is reacted with a compound of the general H-Z and in that, optionally, a resulting hydroxy compound of the formula I wherein A is -CHOH-CHR**1- is treated with a dehydrating agent and/or a resulting compound of the formula I wherein A is -CH=CR**1-, CO-CHR**1- or -CHOH-CHR**1 is treated with a reducing agent and/or a resulting base of the formula is converted to one of its physiologically acceptable acid addition salts by treatment with an acid.